Summary of all possible side effects of capmatinib

Capmatinib (Tabrecta), as a targeted therapy drug targeting MET mutations, has shown significant efficacy in the treatment of non-small cell lung cancer with specific mutations. However, like other medications, capmatinib may come with a range of side effects. Next, let’s take a closer look at the possible side effects of capmatinib.

First, capmatinib may cause lung or breathing problems, the most serious of which is inflammation of the lungs, which can be fatal in extreme cases. Therefore, patients should pay close attention to any new or worsening symptoms, such as cough, fever, difficulty breathing, or shortness of breath while taking capmatinib, and report them to their doctor immediately.

Secondly, the drug may also affect liver function, causing abnormal liver blood test results. Before starting treatment and periodically during treatment, the medical team will perform blood tests to monitor liver function. Patients should seek medical attention immediately if they develop symptoms such as jaundice, dark urine, light stools, fatigue, nausea, vomiting, loss of appetite, or pain on the right side of the stomach.

In addition, capmatinib may cause pancreatic problems, manifested by elevated blood levels of amylase and/or lipase. Symptoms such as upper abdominal pain, weight loss, nausea, and vomiting may be signs of pancreatic damage and require immediate medical attention.

In addition to the above-mentioned organ-specific side effects, capmatinib may also cause allergic reactions, including fever, chills, itching, rash, dizziness, nausea, and vomiting. If these symptoms occur, patients should stop taking the drug immediately and seek medical advice.

At the same time, patients taking capmatinib may also become more sensitive to sunlight and therefore need to pay special attention to sun protection measures.

Common side effects of capmatinib include swelling of the hands and feet, nausea, muscle or bone pain, fatigue and weakness, vomiting, coughing, and loss of appetite. Also, the results of some blood tests may change due to the effects of medications.

The above is a summary of the possible side effects of capmatinib in clinical practice. Overall, this drug, as an effective anti-tumor drug, may bring about a variety of potential side effects. Patients should pay close attention to changes in their symptoms during use and maintain close communication with their doctors to ensure the safety and effectiveness of treatment. At present, capmatinib is only sold overseas. It has both original research version and affordable generic version. Patients should choose according to their needs. When purchasing drugs overseas, be sure to choose formal channels and do not use drugs from unknown sources.